HUMAN PAPILLOMAVIRUS REACTIVATION

HUMAN PAPILLOMAVIRUS REACTIVATION was reported 13 times

These drug classes are most commonly taken by patients reporting HUMAN PAPILLOMAVIRUS REACTIVATION:

# Drug Count
0 Corticosteroid [EPC] 9
1 CD38-directed Cytolytic Antibody [EPC] 7
2 Proteasome Inhibitor [EPC] 7
3 Interleukin-23 Antagonist [EPC] 2
4 Janus Kinase Inhibitor [EPC] 2
5 Integrin Receptor Antagonist [EPC] 1
6 Purine Antimetabolite [EPC] 1